[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma

DV Tudor, I Bâldea, M Lupu, T Kacso… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
With a constantly increasing incidence, cutaneous melanoma has raised the need for a
better understanding of its complex microenvironment that may further guide therapeutic …

[HTML][HTML] Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival

E Panza, P De Cicco, G Ercolano, C Armogida… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The possible correlation between cyclooxygenase-2 (COX-2) expression and disease
progression in melanoma is still a matter of debate. Analysis of COX-2 expression in 45 …

Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression

AC Goulet, JG Einsphar, DS Alberts, A Beas… - Cancer biology & …, 2003 - Taylor & Francis
Cyclooxygenase 2 (COX-2) is an inducible enzyme involved in the production of
prostaglandins and thromboxanes during inflammation. There are now several lines of …

Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth

R Gowda, A Sharma, GP Robertson - Cancer letters, 2017 - Elsevier
Melanoma is a highly drug resistant cancer. To circumvent this problem, a class of
synergistically acting drug combinations, which inhibit multiple key pathways in melanoma …

Celecoxib in cancer therapy and prevention–review

N Tołoczko-Iwaniuk… - Current Drug …, 2019 - ingentaconnect.com
Background and Objectives: It is generally accepted that inflammatory cells found in the
tumor microenvironment are involved in the neoplastic process, promoting cell proliferation …

Celecoxib: a specific COX-2 inhibitor with anticancer properties

AT Koki, JL Masferrer - Cancer control, 2002 - journals.sagepub.com
In addition to the well-established pathophysiological role that COX-2 plays in inflammation,
recent evidence implies that this isoform may also be involved in multiple biologic events …

Cyclooxygenase 2 (COX2) and peroxisome proliferator-activated receptor gamma (PPARG) are stage-dependent prognostic markers of malignant melanoma

S Meyer, T Vogt, M Landthaler, A Berand… - From Molecular to …, 2010 - Springer
COX2 and PPARG are differentially expressed in many human tumors and have emerged
as potential targets of biomodulatory cancer therapy. Using three tissue microarrays (TMA) …

Influencing COX-2 activity by COX related pathways in inflammation and cancer

T Yu, X Lao, H Zheng - Mini reviews in medicinal chemistry, 2016 - ingentaconnect.com
Cancer is a major cause of death worldwide despite significant advances in surgery and
biology. Several recent studies have suggested that there is a close connection between …

Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression

L Kuzbicki, A Sarnecka, BW Chwirot - Melanoma research, 2006 - journals.lww.com
Abstract Cyclooxygenase-2 (COX-2) is an enzyme that plays an important role in the
production of prostaglandins. Numerous studies have demonstrated increased levels of …

Biology of Cox-2: an application in cancer therapeutics

Z Khan, N Khan, RP Tiwari, NK Sah… - Current drug …, 2011 - ingentaconnect.com
Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic
acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed …